EPA Announces Air Quality Improvements and Clean Diesel Grant in Indiana
INDIANA (September 3, 2020) – U.S. Environmental Protection Agency (EPA) and Indiana Department of Environmental Management (IDEM) today announced air quality improvements in Indiana and a $521,201 Diesel Emissions Reduction Act (DERA) grant to reduce diesel emissions throughout the state.
EPA Completes Assessment of National Priorities Sites Following Hurricane Laura
DALLAS – (Sept. 3, 2020) The U.S. Environmental Protection Agency (EPA) has completed inspection of all National Priorities List Superfund sites in counties and parishes with federal disaster declarations following Hurricane Laura.
EPA awards $129,371 to New Mexico Environment Department to monitor air quality
DALLAS – (Sept. 3, 2020) The U.S. Environmental Protection Agency (EPA) recently awarded $129,371 to the New Mexico Environment Department (NMED) to monitor ambient air quality for fine particulate matter (PM 2.5).
Giving Medicine to Children
When young children are sick and cranky, it can be tough to get them to take their medicine. Watch this video for tips from an FDA pediatrician on giving the dose without the battle, in English and Spanish.
Radiation-Emitting Products
From medical X-ray scanners used to see inside the body to surgical lasers used for cosmetic purposes or to improve eyesight, FDA ensures the safety and effectiveness of a wide range or products that emit radiation. To learn more, read these Consumer Updates.
How Many Calories? Keep an Eye on the Menu
FDA's final rule on menu labeling gives consumers the information on calories they need to make informed food choices.
El embarazo: Un etapa para tomar precauciones especiales
Las mujeres embarazadas o nodrizas pueden acudir a la Oficina de Salud de la Mujer de la FDA para obtener información importante de salud, incluyendo datos acerca de los riesgos y beneficios de tomar medicamentos durante este periodo especial.
FDA Encourages More Participation, Diversity in Clinical Trials
The FDA is encouraging more people--including members of diverse racial and ethnic groups, women, and older adults--to participate in clinical trials. Learn why.
